Gilder Gagnon Howe & Co’s Cardiovascular Systems, Inc. CSII Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-11,738	Closed	-$330K	–	311
2017 Q3	$330K	Sell	11,738 -51,913	-82%	-$1.58M	﹤0.01%	235
2017 Q2	$2.05M	Sell	63,651 -1,013	-2%	-$30.9K	0.03%	180
2017 Q1	$1.83M	Buy	+64,664	New	+$1.72M	0.03%	178
2015 Q4	–	Sell	-12,084	Closed	-$191K	–	269
2015 Q3	$191K	Sell	12,084 -6,856	-36%	-$173K	﹤0.01%	224
2015 Q2	$501K	Sell	18,940 -40	-0.2%	-$1.29K	0.01%	230
2015 Q1	$741K	Hold	18,980	–	–	0.01%	213
2014 Q4	$571K	Sell	18,980 -158	-0.8%	-$4.52K	0.01%	219
2014 Q3	$452K	Buy	19,138 +260	+1%	+$7.4K	0.01%	234
2014 Q2	$588K	Sell	18,878 -437	-2%	-$12.6K	0.01%	240
2014 Q1	$614K	Buy	19,315 +803	+4%	+$26.5K	0.01%	224
2013 Q4	$635K	Buy	18,512 +1,951	+12%	+$56.8K	0.01%	216
2013 Q3	$332K	Sell	16,561 -75,601	-82%	-$1.57M	0.01%	229
2013 Q2	$1.95M	Buy	+92,162	New	+$1.79M	0.04%	195

Other funds holding CSII

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Gilder Gagnon Howe & Co's CSII Position: Q4 2017 in Review

Gilder Gagnon Howe & Co sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2017, closing a stake of 11,738 shares — an estimated $330K sold.

Gilder Gagnon Howe & Co first reported a position in CSII in Q2 2013 and held it in 13 quarters. The position peaked at $2.05M in Q2 2017. 134 funds tracked by Wall St. Rank hold CSII as of Q4 2017.

Gilder Gagnon Howe & Co reported no remaining Cardiovascular Systems, Inc. position as of Q4 2017 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 11,738 Cardiovascular Systems, Inc. shares in Q4 2017, an estimated $330K.
Gilder Gagnon Howe & Co first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 13 quarters.
Gilder Gagnon Howe & Co's Cardiovascular Systems, Inc. position peaked at $2.05M in Q2 2017.
134 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2017.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2017, filed 31 Jan 2018.